1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Biphasic Mesothelioma: new trials by email Literature Review of Biphasic Mesothelioma trials Research Report on Biphasic Mesothelioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma Atezolizumab, Cisplatin, Extrapleural Pneumonectomy - Biphasic Mesothelioma, Epithelioid Mesothelioma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 28 | 2018-07-16 | 2026-11-13 |
| Pembrolizumab in Treating Patients With Malignant Mesothelioma Pembrolizumab, Laboratory Biomarker Analysis, Pharmacogenomic Study - Biphasic Mesothelioma, Epithelioid Mesothelioma | Phase 2 | Completed | University of Chicago | 65 | 2015-03-31 | 2026-05-08 |
Mesothelioma, Malignant (2) · Solitary Fibrous Tumor, Pleural (1)
Adenoma (2) · Lung Diseases (2) · Lung Neoplasms (2) · Mesothelioma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Mesothelial (2) · Pleural Neoplasms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1)
1,2-diaminocyclohexaneplatinum II citrate (1) · Cisplatin (1) · Pemetrexed (1) · Pharmacogenomic Testing (1) · Platinum (1) · Radiation (1) · Radiotherapy (1) · atezolizumab (1) · pembrolizumab (1)
National Cancer Institute (NCI) (1) · University of Chicago (1)
United States (2)
Anne S Tsao (1) · Hedy Kindler (1)
P30CA014599 (1), U10CA180888 (1)